Cargando…
Pegaptanib sodium treatment in neovascular age-related macular degeneration: clinical experience in Germany
BACKGROUND: The VEGF Inhibition Study In Ocular Neovascularisation (VISION) reported the efficacy of intravitreal (ITV) vascular endothelial growth factor (VEGF) inhibition with pegaptanib sodium (Macugen(®)) for the treatment of neovascular age-related macular degeneration (AMD). This paper reports...
Autores principales: | Feucht, Nikolaus, Matthias, Huebner, Lohmann, Chris P, Maier, Mathias |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693993/ https://www.ncbi.nlm.nih.gov/pubmed/19668713 |
Ejemplares similares
-
Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK
por: Sivaprasad, Sobha, et al.
Publicado: (2008) -
Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration
por: Sivaprasad, Sobha
Publicado: (2008) -
Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study
por: Friberg, Thomas R, et al.
Publicado: (2010) -
Pegaptanib in the treatment of wet, age-related macular degeneration
por: Vinores, Stanley A
Publicado: (2006) -
Pegaptanib Sodium versus Pegaptanib Sodium Combined with Macular Laser Photocoagulation or Laser Alone for Diabetic Macular Edema
por: Querques, G., et al.
Publicado: (2009)